N🟁N

DSM announces management appointments

  //business-finance.news-articles.net/content/2009/12/16/dsm-announces-management-appointments.html
  Published in Business and Finance on Wednesday, December 16th 2009 at 1:33 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

HEERLEN, THE NETHERLANDS--(Marketwire - December 16, 2009) -

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management changes:

Mr. Gerard de Reuver (1956), currently Director of Strategic Projects, will be appointed business group director DSM Dyneema as of 1 April 2010. Mr. de Reuver?s current responsibilities, which include managing a dedicated taskforce to deal with the changed economic environment as well as a culture change program, have now been transferred to the business groups, with a coordinating role for Corporate Finance and Corporate Human Resources, respectively. Mr. de Reuver, will report to Mr. Nico Gerardu, member of the DSM Managing Board.

Mr. Christophe Dardel (1960) at present business group director of DSM Dyneema, will be appointed President of DSM Biomedical as of 15 May 2010. Mr. Dardel has developed DSM Dyneema to its current level and will now have the responsibility of growing the DSM Biomedical business. In his new role he will report to Mr. Rob van Leen, DSM Chief Innovation Officer.

Mr. Steve Hartig (1958) currently President of DSM Biomedical, will support Mr. Dardel through the transition and will then be promoted to his next leadership role with DSM. Mr. Hartig has taken DSM Biomedical from concept to a growing business reality. An announcement regarding his new role will be made on a later date.

DSM ? the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM?s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: [ www.dsm.com ].

 For more information: DSM Corporate Communications Hans Vossen tel. +31 (0) 45 5782864 Herman Betten fax +31 (0) 45 5782595 tel. +31 (0) 45 5782017 e-mail [ investor.relations@dsm.com ] fax +31 (0) 45 5740680 e-mail [ media.relations@dsm.com ]

[HUG#1362185]

Press release-pdf: [ http://hugin.info/130663/R/1362185/332556.pdf ]